Development of a Nationally Scalable Model of Group Prenatal Care to Improve Birth Outcomes: "Expect With Me"

Sponsor
Yale University (Other)
Overall Status
Completed
CT.gov ID
NCT02169024
Collaborator
United Health Foundation (Other)
2,402
2
2
46
1201
26.1

Study Details

Study Description

Brief Summary

This study addresses the intractable challenges of adverse birth outcomes, including preterm delivery and low birthweight, by proposing the development, implementation and evaluation of a model of group prenatal care that could be scaled nationally. Group prenatal care models have been demonstrated through rigorous research to provide significantly improved birth outcomes with implications for maternal-child health and substantial cost savings. However, group prenatal care is currently available to only a small fraction of the more than four million women who give birth annually in the US. Through the development, implementation and evaluation of a new model of group prenatal care, we will create an outcomes-focused model of group prenatal care that will be scalable nationally with an eye toward improving US birth outcomes.

The long-term objective of the proposed study is to reduce the risk for adverse perinatal outcomes during and after pregnancy among women and families receiving prenatal care in health centers in 3 geographic locations serving vulnerable populations: Hidalgo County Texas, Nashville Tennessee, and Detroit Michigan. We will develop, disseminate, and evaluate a new and improved model of group prenatal care, "Expect with Me," based on our previous research on group models of prenatal care, which has already yielded favorable behavioral and biological results in two randomized controlled trials.

We hypothesize that, relative to women who receive standard individual prenatal care, the women who receive "Expect with Me" group prenatal care will be significantly more likely to:

  1. have better perinatal outcomes, including better health behaviors during pregnancy (e.g., nutrition, physical activity), better birth outcomes (e.g., decreased preterm labor, low birthweight, Neonatal Intensive Care Unit stays), and better postpartum indicators (e.g., increased breastfeeding);

  2. report greater change in risk-related behaviors and psychosocial characteristics that could be considered potential mechanisms for the program's effectiveness;

  3. have lower rates of sexually transmitted diseases and rapid repeat pregnancy one year postpartum;

  4. have lower healthcare costs through improved outcomes (e.g., appropriate care utilization, fewer complications, reduced NICU admissions/length of stays)

Comparisons based on propensity-score matched sample of women receiving standard individual prenatal care at the same clinical sites.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Expect With Me group prenatal care
  • Other: Standard individual prenatal care
N/A

Detailed Description

This study addresses the intractable challenges of adverse birth outcomes, including preterm delivery and low birthweight, by proposing the development, implementation and evaluation of a model of group prenatal care that could be scaled nationally. Group prenatal care models have been demonstrated through rigorous research to provide significantly improved birth outcomes with implications for maternal-child health and substantial cost savings. However, group prenatal care is currently available to only a small fraction of the more than four million women who give birth annually in the US. Through the development, implementation and evaluation of a new model of group prenatal care, we will create an outcomes-focused model of group prenatal care that will be scalable nationally with an eye toward improving US birth outcomes.

Specific Aims:

The long-term objective of the proposed study is to reduce the risk for adverse perinatal outcomes during and after pregnancy among women and families receiving prenatal care in health centers in 3 geographic locations serving vulnerable populations: Hidalgo County Texas, Nashville Tennessee, and Detroit Michigan. We will develop, disseminate, and evaluate a new and improved model of group prenatal care, "Expect with Me," based on our previous research on group models of prenatal care, which has already yielded favorable behavioral and biological results in two randomized controlled trials. The overall objective of this project is to improve maternal health and reduce adverse birth outcomes. We will meet this objective by achieving three specific goals:

  1. Develop a new and improved model of group prenatal care, including curriculum, training materials, IT infrastructure and marketing materials to support broad adoption of group prenatal care, enhance consumer experience, monitor patient outcomes, and ensure national scalability.

  2. Implement group prenatal care in three communities at high risk for adverse perinatal outcomes (Hidalgo County TX, Nashville TN, Detroit MI), engaging and training providers in group facilitation and the established curriculum, engaging patients through improved in-reach and outreach strategies, and implementing IT infrastructure to improve uptake, patient experience, and sustainability through the monitoring of patient outcomes.

  3. Evaluate the effect of implementing group prenatal care through a rigorous process and outcome evaluation that identifies any barriers to national scalability and examines maternal health and birth outcomes and resultant cost implications.

Specific Study Hypotheses

We hypothesize that, relative to women who receive standard individual prenatal care, the women who receive "Expect with Me" group prenatal care will be significantly more likely to:

  1. have better perinatal outcomes, including better health behaviors during pregnancy (e.g., nutrition, physical activity), better birth outcomes (e.g., decreased preterm labor, low birthweight, Neonatal Intensive Care Unit stays), and better postpartum indicators (e.g., increased breastfeeding);

  2. report greater change in risk-related behaviors and psychosocial characteristics that could be considered potential mechanisms for the program's effectiveness;

  3. have lower rates of sexually transmitted diseases and rapid repeat pregnancy one year postpartum;

  4. have lower healthcare costs through improved outcomes (e.g., appropriate care utilization, fewer complications, reduced NICU admissions/length of stays)

Study Design

Study Type:
Interventional
Actual Enrollment :
2402 participants
Allocation:
Non-Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Expect With Me group prenatal care vs. Individual Care Only prenatal careExpect With Me group prenatal care vs. Individual Care Only prenatal care
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
Development of a Nationally Scalable Model of Group Prenatal Care to Improve Birth Outcomes: "Expect With Me"
Actual Study Start Date :
Feb 1, 2014
Actual Primary Completion Date :
Dec 1, 2016
Actual Study Completion Date :
Dec 1, 2017

Arms and Interventions

Arm Intervention/Treatment
Experimental: Expect With Me group prenatal care

receiving prenatal care through an Expect With Me group

Behavioral: Expect With Me group prenatal care
Expect With Me group prenatal care was designed based on: principles of group care; evidence from RCTs demonstrating improved birth outcomes; ACOG clinical guidelines; and research on patient and provider engagement through technology. Designed with national dissemination as a primary consideration, Expect With Me incorporates best evidence-based aspects of existing models of group care, with a novel IT platform to improve patient engagement and support, enhance health behaviors and decision making, connect providers and patients, and improve health service delivery. Expect With Me provides care to groups of 8-12 women of the same gestational age, implemented after initial individual assessment through delivery. Group visits are 90-120 minutes each, and follow a structured curriculum that incorporates standard content of prenatal care, and emphasizes critical health issues relevant to pregnancy, such as nutrition, physical activity, stress/mental health and sexual health.
Other Names:
  • group prenatal care
  • Active Comparator: Individual Care Only

    Standard of Care- individual prenatal care

    Other: Standard individual prenatal care
    Standard of care- individual prenatal care
    Other Names:
  • Individual Care Only
  • Outcome Measures

    Primary Outcome Measures

    1. Risk of preterm birth incidence [up to 37 weeks gestation]

      Incidence risk of delivery before 37 weeks gestation

    2. Risk of low birth weight incidence [delivery]

      Incidence risk of infant weight at birth < 2500 grams

    3. Risk of small for gestational age incidence [delivery]

      Incidence risk of infant weight below the 10th percentile for the gestational age at birth

    4. Risk of neonatal intensive care unit (NICU) admission incidence [birth]

      Incidence risk of being admitted to the neonatal intensive care unit (NICU) at birth

    Secondary Outcome Measures

    1. breastfeeding [6 and 12 months postpartum]

      initiation and duration of breastfeeding

    2. nutrition [2nd and 3rd trimester of pregnancy and 6 and 12 months postpartum]

      nutritional choices, food security, and use of mindful eating practices

    3. physical activity [2nd and 3rd trimester and 6 and 12 months postpartum]

      level of physical activity in a typical week

    4. readiness for labor and delivery [measured at 2nd and third trimester]

      readiness for labor and delivery

    5. readiness for taking care of baby [2nd and 3rd trimester of pregnancy]

      readiness for taking care of baby

    6. social support [2nd and 3rd trimester and 6 and 12 months postpartum]

      multidimensional scale of perceived social support subscale

    7. condom use self-efficacy [2nd and 3rd trimester and 6 and 12 months postpartum]

      condom use self efficacy scale

    8. substance use [2nd and 3rd trimester and 6 and 12 months postpartum]

      use of cigarettes, alcohol, and drugs

    9. care satisfaction [3rd trimester]

      satisfaction with Expect With Me group prenatal care and use of program components

    10. adherence to medical recommendations [6 & 12 months postpartum]

      adherence to medical recommendations (e.g., 6-week postpartum check, pediatric visits, vaccinations, infant feeding)

    11. postpartum body mass index [measured at 6 and 12 months postpartum]

      individual's body weight divided by the square of their height (kg/m2)

    12. maternal weight gain [measured at 2nd and 3rd trimester and birth]

      weight gain as compared to medical recommendations

    13. mode of delivery [delivery]

      mode of delivery (e.g., cesarean, vaginal)

    14. sexual risk: condom use [measured at 2nd and 3rd trimester and 6 and 12 months postpartum]

      condom use percent (0-100%)

    15. sexual risk: contraceptive use (LARC) [measured at 2nd and 3rd trimester and 6 and 12 months postpartum]

      use of other contraceptives to prevent pregnancy (no/yes)

    16. sexual risk: number of sexual partners [measured at 2nd and 3rd trimester and 6 and 12 months postpartum]

      number of partners

    17. sexual risk: sexually transmitted infection [measured at 2nd and 3rd trimester and 6 and 12 months postpartum]

      sexually transmitted infection (no/yes, during pregnancy or incident postpartum)

    Other Outcome Measures

    1. nurse visitation [2nd and 3rd trimester of pregnancy]

      participation in a nurse visitation program

    2. sexual debut [2nd trimester pregnancy]

      age at first intercourse

    3. living situation [2nd and 3rd trimester and 6 and 12 months postpartum]

      where and with whom they live with and the stability of their housing

    4. transfer of motivation [2nd and3rd trimester and 6 and 12 months postpartum]

      relation of motivation for self and baby's health

    5. confidence in parenting skills [6 and 12 months postpartum]

      confidence in parenting skills

    6. intimate partner violence [measured at 2nd and 3rd trimester and 6 and 12 months postpartum]

      perpetration and victimization of violence by an intimate partner

    7. perceived stress [2nd and 3rd trimester and 6 and 12 months postpartum]

      stress level as reported by patient

    8. depressive symptomatology [2nd and 3rd trimester of pregnancy]

      patient endorsement of depressive symptoms

    9. perceived discrimination [2nd and 3rd trimester of pregnancy and 6 and 12 months postpartum]

      patient experiences of discrimination

    10. resilience [2nd and 3rd trimester of pregnancy and 6 and 12 months postpartum]

      shift and persist scale

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    N/A and Older
    Sexes Eligible for Study:
    Female
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • less than 24 weeks pregnant

    • able to attend groups conducted in English or Spanish

    • consent to share their data with the study

    Exclusion Criteria:
    • severe medical problem requiring individual care only, as determined by the participating clinical practice

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Wayne State University Detroit Michigan United States 48201
    2 Vanderbilt University Medical Center Nashville Tennessee United States 37232

    Sponsors and Collaborators

    • Yale University
    • United Health Foundation

    Investigators

    • Principal Investigator: Jeannette R Ickovics, Ph.D., Yale School of Public Health
    • Study Director: Jessica B Lewis, PhD, MFT, Yale School of Public Health

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Yale University
    ClinicalTrials.gov Identifier:
    NCT02169024
    Other Study ID Numbers:
    • 1304011772
    First Posted:
    Jun 20, 2014
    Last Update Posted:
    May 29, 2020
    Last Verified:
    May 1, 2020
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Yale University
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of May 29, 2020